Filing Details

Accession Number:
0001104659-23-027555
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-03-01 21:46:27
Reporting Period:
2022-10-04
Accepted Time:
2023-03-01 21:46:27
Original Submission Date:
2022-10-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1867066 Journey Medical Corp DERM () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588538 Robert Ernest Paolantonio De C/O Journey Medical Corporation,
9237 E Via Deventura Blvd., Suite 105
Scottsdale AZ 85258
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2022-10-04 10,093 $2.41 259,907 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In connection with the vesting of 40,000 shares on October 1, 2022, a total of 10,093 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  2. Due to a clerical error, the original Form 4 filed on October 6, 2022 reflected an acquisition of 10,029 shares in lieu of a disposition of 10,029 shares. The amount of securities beneficially owned following the reported transaction reported in the previously filed Form 4 is correct.
  3. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 4, 2022, was $2.38 to $2.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Includes restricted stock units, which vest over various time periods.